0001493152-23-017921.txt : 20230620 0001493152-23-017921.hdr.sgml : 20230620 20230517141311 ACCESSION NUMBER: 0001493152-23-017921 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20230517 FILER: COMPANY DATA: COMPANY CONFORMED NAME: RenovoRx, Inc. CENTRAL INDEX KEY: 0001574094 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 271448452 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 333 W. SANTA CLARA STREET, SUITE 900 CITY: SAN JOSE STATE: CA ZIP: 95110 BUSINESS PHONE: 408-800-2649 MAIL ADDRESS: STREET 1: 333 W. SANTA CLARA STREET, SUITE 900 CITY: SAN JOSE STATE: CA ZIP: 95110 CORRESP 1 filename1.htm

RenovoRx, Inc.

4546 El Camino Real, Suite B1

Los Altos, California 94022

May 17, 2023

VIA EDGAR

Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

	Re:	RenovoRx, Inc.
		Registration Statement on Form S-3
		Filed May 12, 2023
		File No. 333-271882

Acceleration Request

	Requested Date:	May 19, 2023
	Requested Time:	4:00 p.m. Eastern Time,
		or as soon thereafter as practicable

Ladies and Gentlemen:

Pursuant to Rule 461 under the Securities Act of 1933, as amended, RenovoRx, Inc. (the “Company”) hereby respectfully requests that the above-referenced Registration Statement on Form S-3 (File No. 333-271882) (the “Registration Statement”) be declared effective at the “Requested Date” and “Requested Time” set forth above or at such later time as the Company or its counsel may orally request via telephone call to the staff of the Division of Corporation Finance of the Securities and Exchange Commission.

Once the Registration Statement has been declared effective, please orally confirm that event with our counsel, Wilson Sonsini Goodrich & Rosati, Professional Corporation, by calling Michael Coke at (650) 565-3596.

Please direct any questions or comments regarding this acceleration request to Michael Coke.

	Very truly yours,

	RenovoRx, Inc.

	/s/ Shaun R. Bagai

	Shaun R. Bagai
	Chief Executive Officer

cc:	Michael E. Coke, Wilson Sonsini Goodrich & Rosati, Professional Corporation